Improved survival of TNF-deficient mice during the zymosan-induced multiple organ dysfunction syndrome

被引:49
作者
Volman, TJH
Hendriks, T
Verhofstad, AAJ
Kullberg, BJ
Goris, RJA
机构
[1] Univ Nijmegen, Med Ctr St Radboud, Dept Surg, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr St Radboud, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen, Med Ctr St Radboud, Dept Med, NL-6500 HB Nijmegen, Netherlands
来源
SHOCK | 2002年 / 17卷 / 06期
关键词
tumor necrosis factor; knock-out mice; zymosan; MODS; cytokines;
D O I
10.1097/00024382-200206000-00005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The purpose of the study was to investigate the course of the zymosan-induced multiple organ dysfunction syndrome (MODS) in the absence of tumor necrosis factor (TNF) in a murine model. Tumor Necrosis Factor-alpha-lymphotoxin-alpha knockout (TNF/LT-/-) mice (n = 36) and wild-type (TNF/LT+/+) mice (n = 36) received 40 mug of lipopolysaccharide (LIPS) intraperitoneally followed by zymosan at a dose of 1 mg/g body weight 6 days later (day 0). Animals were monitored daily for body weight and temperature and clinical symptoms. At day 22, most of the surviving mice were killed to examine organ weight and histology. A small number of animals were followed until day 48. In all animals, zymosan induced an acute sterile peritonitis phase followed by an apparent recovery. From day 8 onwards the TNF/LT+/+ mice entered a third-MODS-like-phase, characterized by loss of body weight, decreased body temperature, and significant mortality. At day 22, survival in the TNF/LT-/- mice (92%) was significantly (P = 0.01) higher than in the TNF/LT+/+ mice (60%). In addition, average body temperature and average relative (vs. weight at day 0) body weight were higher in the TNF/LT-/- mice than in the TNF/LT+/+ mice (35.9degreesC and 100degrees vs. 33.3degreesC and 84%, respectively). However, at this time point, surviving animals from both groups showed similar and significant organ damage, indicated by an increase in absolute and relative (vs body weight) weight of lung, spleen, and liver (liver only in the TNF/LT-/- mice). Moreover, histopathological examination of organs from the surviving animals showed a similar degree of microscopic damage in both groups. Interestingly, besides mononuclear cells, inflammatory infiltrates in lungs and livers of TNF/LT+/+ but not of TNF-/- mice contained neutrophils. In conclusion, TNF-deficient mice exhibit significantly improved morbidity and mortality during zymosan-induced MODS. However, the absence of TNF does not completely protect against MODS in this murine model.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 35 条
[1]   Mice heterozygous for a deletion of the tumor necrosis factor-alpha and lymphotoxin-alpha genes: Biological importance of a nonlinear response of tumor necrosis factor-alpha to gene dosage [J].
Amiot, F ;
Boussadia, O ;
Cases, S ;
Fitting, C ;
Lebastard, M ;
Cavaillon, JM ;
Milon, G ;
Dautry, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) :1035-1042
[2]  
Baue AE, 1997, ARCH SURG-CHICAGO, V132, P703
[3]   Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): Are we winning the battle? [J].
Baue, AE ;
Durham, R ;
Faist, E .
SHOCK, 1998, 10 (02) :79-89
[4]   MULTIPLE ORGAN FAILURE SYNDROME IN THE 1990S - SYSTEMIC INFLAMMATORY RESPONSE AND ORGAN DYSFUNCTION [J].
BEAL, AL ;
CERRA, FB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (03) :226-233
[5]  
Bemelmans MHA, 1996, CRIT REV IMMUNOL, V16, P1
[7]   The role of tumor necrosis factor in the development of multiple organ failure in a murine model [J].
Burdon, D ;
Tiedje, T ;
Pfeffer, K ;
Vollmer, E ;
Zabel, P .
CRITICAL CARE MEDICINE, 2000, 28 (06) :1962-1967
[8]   Nuclear factor κB:: a pivotal role in the systemic inflammatory response syndrome and new target for therapy [J].
Christman, JW ;
Lancaster, LH ;
Blackwell, TS .
INTENSIVE CARE MEDICINE, 1998, 24 (11) :1131-1138
[9]   Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide [J].
Cuzzocrea, S ;
Zingarelli, B ;
Sautebin, L ;
Rizzo, A ;
Crisafulli, C ;
Campo, GM ;
Costantino, G ;
Calapai, G ;
Nava, F ;
DiRosa, M ;
Caputi, AP .
SHOCK, 1997, 8 (04) :268-275
[10]  
Cuzzocrea S, 1999, EUR CYTOKINE NETW, V10, P191